Cargando…

Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors

Resistant viruses containing mutant neuraminidases (NAs) with diminished drug affinity continue to emerge, and new anti-influenza agents are urgently required. Several potent inhibitors targeting the hydrophobic 150-cavity of viral NAs have been developed by modifying the antiviral drugs, oseltamivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pengfei, Oladejo, Babayemi O., Li, Chenning, Fu, Lifeng, Zhang, Shanshan, Qi, Jianxun, Lv, Xun, Li, Xuebing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2021
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696196/ https://www.ncbi.nlm.nih.gov/pubmed/35423449 http://dx.doi.org/10.1039/d1ra00472g

Ejemplares similares

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
por: Zhang, Jiwei, et al.
Publicado: (2023)

A Novel I221L Substitution in Neuraminidase Confers High-Level Resistance to Oseltamivir in Influenza B Viruses
por: Escuret, Vanessa, et al.
Publicado: (2014)

Binding mechanism of oseltamivir and influenza neuraminidase suggests perspectives for the design of new anti-influenza drugs
por: Tao, Jiaye, et al.
Publicado: (2022)

Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus
por: Jiang, Haihai, et al.
Publicado: (2020)

Synthesis of 1,2,3-triazolyl nucleoside analogues and their antiviral activity
por: Andreeva, Olga V., et al.
Publicado: (2020)

Design, Synthesis, Spectroscopic Characterisation and In Vitro Cytostatic Evaluation of Novel Bis(coumarin-1,2,3-triazolyl)benzenes and Hybrid Coumarin-1,2,3-triazolyl-aryl Derivatives
por: Pršir, Kristina, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of NH(2)-Sulfonyl Oseltamivir Analogues as Influenza Neuraminidase Inhibitors
por: Hu, Yaping, et al.
Publicado: (2019)

Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin
por: Park, Gab-Man, et al.
Publicado: (2017)

Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives
por: Macan, Andrijana Meščić, et al.
Publicado: (2019)

Design, Synthesis, and Biological Activities of Novel 2-Cyanoacrylate Compounds Containing Substituted Pyrazolyl or 1,2,3-Triazolyl Moiety
por: Wang, Yang, et al.
Publicado: (2023)

Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness
por: de Oliveira, Joana T., et al.
Publicado: (2015)

The Antioxidant and Antiproliferative Activities of 1,2,3-Triazolyl-L-Ascorbic Acid Derivatives
por: Harej, Anja, et al.
Publicado: (2019)

Oseltamivir Resistance in Influenza A(H6N2) Caused by an R292K Substitution in Neuraminidase Is Not Maintained in Mallards without Drug Pressure
por: Gillman, Anna, et al.
Publicado: (2015)

A Computational-Experimental Approach Identifies Mutations That Enhance Surface Expression of an Oseltamivir-Resistant Influenza Neuraminidase
por: Bloom, Jesse D., et al.
Publicado: (2011)

In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015)

Antimycobacterial Activities of Novel 5-(1H-1,2,3-Triazolyl)Methyl Oxazolidinones
por: Phillips, Oludotun Adebayo, et al.
Publicado: (2012)

Design, Synthesis, Biological Evaluation and In Silico Studies of Pyrazole-Based NH(2)-Acyl Oseltamivir Analogues as Potent Neuraminidase Inhibitors
por: Ye, Jiqing, et al.
Publicado: (2021)

Antimycobacterial Activities of N-Substituted-Glycinyl 1H-1,2,3-Triazolyl Oxazolidinones and Analytical Method Development and Validation for a Representative Compound
por: Al-Tannak, Naser F., et al.
Publicado: (2017)

Epistatic interactions between neuraminidase mutations facilitated the emergence of the oseltamivir-resistant H1N1 influenza viruses
por: Duan, Susu, et al.
Publicado: (2014)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
por: Xu, Zhichao, et al.
Publicado: (2022)

Influenza A(H7N9) Virus Acquires Resistance-Related Neuraminidase I222T Substitution When Infected Mallards Are Exposed to Low Levels of Oseltamivir in Water
por: Gillman, Anna, et al.
Publicado: (2015)

Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2009)

Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice
por: Tang, Jing, et al.
Publicado: (2021)

Enzymatic Properties of the Neuraminidase of Seasonal H1N1 Influenza Viruses Provide Insights for the Emergence of Natural Resistance to Oseltamivir
por: Rameix-Welti, Marie-Anne, et al.
Publicado: (2008)

Dry extract BNO 1011 inhibits human influenza a replication and neuraminidase activity in oseltamivir-resistant and -sensitive viral strains
por: Seifert, Stephanie, et al.
Publicado: (2013)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Regioselective Synthesis of NO-Donor (4-Nitro-1,2,3-triazolyl)furoxans via Eliminative Azide–Olefin Cycloaddition
por: Stebletsova, Irina A., et al.
Publicado: (2023)

Correction: Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases
por: Hashem, Anwar M., et al.
Publicado: (2013)

Deletions of neuraminidase and resistance to oseltamivir may be a consequence of restricted receptor specificity in recent H3N2 influenza viruses
por: Gulati, Shelly, et al.
Publicado: (2009)

Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
por: Adlhoch, Cornelia, et al.
Publicado: (2023)

Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K
por: Tran-To Su, Chinh, et al.
Publicado: (2013)

Photophysical and Electrical Properties of Highly Luminescent 2/6-Triazolyl-Substituted Push–Pull Purines
por: Sebris, Armands, et al.
Publicado: (2022)

Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase
por: van der Vries, E., et al.
Publicado: (2010)

Evaluation of Mono and Bimetallic Ferrocene-Based 1,2,3-Triazolyl Compounds as Burning Rate Catalysts for Solid Rocket Motor
por: Valdebenito, Cristian, et al.
Publicado: (2023)

Influenza Virus Neuraminidase: Structure and Function
por: Shtyrya, Y.A., et al.
Publicado: (2009)

Discovery of Novel Boron-Containing N-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
por: Jia, Ruifang, et al.
Publicado: (2022)

1,4-Disubstituted-[1,2,3]triazolyl-Containing Analogues of MT-II: Design, Synthesis, Conformational Analysis, and Biological Activity
por: Testa, Chiara, et al.
Publicado: (2014)

Estimating the Fitness Advantage Conferred by Permissive Neuraminidase Mutations in Recent Oseltamivir-Resistant A(H1N1)pdm09 Influenza Viruses
por: Butler, Jeff, et al.
Publicado: (2014)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses
por: Singh, Ashona, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p1224lbj1bqnooiov25eb5js66